A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lung Cancer
Study Identifier
H24-281
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80%-85% of lung cancers cases of which 60% are non-squamous (NSQ). This study will evaluate the prevalence of mesenchymal epithelial transition (MET) overexpression (OE) in adult participants with advanced or metastatic NSQ NSCLC.
Archived tissue biopsies will be tested for MET OE and data from approximately 500 participants will be collected. No participants will be enrolled in this study.
Participants' charts will be reviewed. No drug will be administered as a part of this study. The duration of the study will be approximately 15 months.
There is no additional burden for participants in this trial.
Study Locations
Location
Status
Location
Hospital Italiano de Buenos Aires /ID# 256999
Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina, 1199
Status
Not applicable
Location
Instituto Alexander Fleming /ID# 256295
Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina, 1426
Status
Not applicable
Location
Irmandade da Santa Casa de Misericordia de Porto Alegre /ID# 256487
Porto Alegre, Rio Grande Do Sul, Brazil, 90020-090
Status
Not applicable
Location
Hospital Alemao Oswaldo Cruz /ID# 256486
São Paulo, Brazil, 01323-020
Status
Not applicable
Location
Nova Scotia Health Authority /ID# 256950
Halifax, Nova Scotia, Canada, B3H 1V8
Status
Not applicable
Location
Institut universitaire de cardiologie et de pneumologie de Québec - Université L /ID# 257872
Québec, Quebec, Canada, G1V 4G5
Status
Not applicable
Showing {first} - {last} of {total} Results